GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,051,000 | +80.0% | 15,431 | -15.6% | 0.00% | +200.0% |
Q2 2022 | $584,000 | -14.6% | 18,278 | -7.4% | 0.00% | 0.0% |
Q1 2022 | $684,000 | +6.0% | 19,738 | -10.4% | 0.00% | 0.0% |
Q4 2021 | $645,000 | +9.0% | 22,027 | -5.2% | 0.00% | 0.0% |
Q3 2021 | $592,000 | -28.8% | 23,223 | -2.1% | 0.00% | -50.0% |
Q2 2021 | $831,000 | -45.3% | 23,727 | -36.4% | 0.00% | -60.0% |
Q1 2021 | $1,520,000 | -12.5% | 37,301 | -7.0% | 0.01% | -16.7% |
Q4 2020 | $1,737,000 | -20.4% | 40,105 | +1.3% | 0.01% | -33.3% |
Q3 2020 | $2,182,000 | +65.1% | 39,575 | +89.0% | 0.01% | +50.0% |
Q2 2020 | $1,322,000 | +26.1% | 20,935 | +2.1% | 0.01% | 0.0% |
Q1 2020 | $1,048,000 | +27.6% | 20,511 | +98.7% | 0.01% | +50.0% |
Q4 2019 | $821,000 | +65.9% | 10,323 | +1.2% | 0.00% | +33.3% |
Q3 2019 | $495,000 | +31.6% | 10,196 | +42.5% | 0.00% | +50.0% |
Q2 2019 | $376,000 | -20.7% | 7,153 | -20.1% | 0.00% | 0.0% |
Q1 2019 | $474,000 | +42.8% | 8,947 | +10.6% | 0.00% | 0.0% |
Q4 2018 | $332,000 | -31.1% | 8,093 | -36.2% | 0.00% | 0.0% |
Q3 2018 | $482,000 | +48.8% | 12,688 | +77.1% | 0.00% | 0.0% |
Q2 2018 | $324,000 | -6.4% | 7,165 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $346,000 | +13.1% | 7,165 | -8.0% | 0.00% | 0.0% |
Q4 2017 | $306,000 | +29.1% | 7,784 | +2.1% | 0.00% | 0.0% |
Q3 2017 | $237,000 | – | 7,621 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |